(Q30747693)

26 June 2017

A New Bliss Independence Model to Analyze Drug Combination Data (English)

1 reference

26 June 2017

Wei Zhao

1

1 reference

26 June 2017

Kris Sachsenmeier

2

1 reference

26 June 2017

Lanju Zhang

3

1 reference

26 June 2017

Erin Sult

4

1 reference

26 June 2017

Robert E Hollingsworth

5

1 reference

26 June 2017

Harry Yang

6

1 reference

26 June 2017

3 February 2014

1 reference

Journal of Biomolecular Screening

26 June 2017

1 reference

26 June 2017

19

1 reference

26 June 2017

817-821

1 reference

26 June 2017

5

1 reference

Rational design of cancer-drug combinations

26 June 2017

1 reference

https://api.crossref.org/works/10.1177%2F1087057114521867

Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057114521867

A simple test for synergy for a small number of combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057114521867

Recent clinical developments and rationale for combining targeted agents in non-small cell lung cancer (NSCLC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057114521867

Relationships of insulin-like growth factor-1 receptor and epidermal growth factor receptor expression to clinical outcomes in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057114521867

The EGF receptor interacts with the type 1 IGF receptor and regulates its stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057114521867

Activation of the insulin-like growth factor-1 receptor induces resistance to epidermal growth factor receptor antagonism in head and neck squamous carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057114521867

A stable IgG-like bispecific antibody targeting the epidermal growth factor receptor and the type I insulin-like growth factor receptor demonstrates superior anti-tumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057114521867

Dual inhibition of epidermal growth factor receptor and insulin-like growth factor receptor I: reduction of angiogenesis and tumor growth in cutaneous squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057114521867

21 January 2018

Identifiers

DOI

10.1177/1087057114521867

1 reference

26 June 2017

1 reference